このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Kingworld Medicines Group バランスシートの健全性
財務の健全性 基準チェック /56
Kingworld Medicines Groupの総株主資本はCN¥699.4M 、総負債はCN¥342.1Mで、負債比率は48.9%となります。総資産と総負債はそれぞれCN¥1.3BとCN¥638.3Mです。 Kingworld Medicines Groupの EBIT はCN¥78.7Mで、利息カバレッジ比率-39339です。現金および短期投資はCN¥194.0Mです。
主要情報
48.9%
負債資本比率
CN¥342.13m
負債
| インタレスト・カバレッジ・レシオ | -39339x |
| 現金 | CN¥194.03m |
| エクイティ | CN¥699.35m |
| 負債合計 | CN¥638.30m |
| 総資産 | CN¥1.34b |
財務の健全性に関する最新情報
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05Recent updates
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22財務状況分析
短期負債: 1110の 短期資産 ( CN¥588.6M ) が 短期負債 ( CN¥463.5M ) を超えています。
長期負債: 1110の短期資産 ( CN¥588.6M ) が 長期負債 ( CN¥174.8M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 1110の 純負債対資本比率 ( 21.2% ) は 満足できる 水準であると考えられます。
負債の削減: 1110の負債対資本比率は、過去 5 年間で52.8%から48.9%に減少しました。
債務返済能力: 1110の負債は 営業キャッシュフロー によって 十分にカバーされていません ( 12.4% )。
インタレストカバレッジ: 1110支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。